Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the latter part of the year.
Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug
Categories:
Related Post
Tom Homan threatens criminal prosecution after activists post photos of ICE agentsTom Homan threatens criminal prosecution after activists post photos of ICE agents
Border czar Tom Homan is threatening legal action after anti-ICE activists posted the photos, names and addresses of ICE agents operating in Southern California. Homan told “Fox & Friends” Wednesday
To calm frayed nerves in US & Europe, PM Modi may visit Ukraine next monthTo calm frayed nerves in US & Europe, PM Modi may visit Ukraine next month
PM Narendra Modi considered visiting Ukraine in August to balance the Russia-Ukraine conflict and address concerns from the US and Europe about his recent trip to Russia. This would be
The negative repercussions of multitasking on our healthThe negative repercussions of multitasking on our health
Research suggests the human brain is not wired to multitask on complicated tasks, and experts say it can cause more damage to our wellbeing than we realize. Dr. Jon LaPook